Neprilysin Inhibitor May Increase Urinary C-Peptide Excretion

Diabetes Care. 2022 Aug 1;45(8):e122-e123. doi: 10.2337/dc22-0538.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antihypertensive Agents* / pharmacology
  • Atrial Natriuretic Factor / pharmacology
  • Blood Pressure
  • C-Peptide
  • Humans
  • Neprilysin* / pharmacology

Substances

  • Antihypertensive Agents
  • C-Peptide
  • Atrial Natriuretic Factor
  • Neprilysin